Tagged digital-pathology
Press Release
PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation
PharmaNest, a leader in high-resolution, single-fiber quantitative Digital Pathology and Artificial Intelligence, showcases the performance of its FibroNest Ph-FCS digital biomarker for quantifying fibrosis severity and its clinical utility in Phase 2 and Phase 3 studies for patients with Metabolic Associated Steatohepatitis (MASH). Read More
Press Release
CGI and Tribun Health Selected to Lead Digital Pathology Transformation in Region Sjælland
CGI (TSX: GIB.A) (NYSE: GIB), one of the largest IT and business consulting companies in the world, and Tribun Health, a rising force in healthcare technology, announce their partnership with Region Sjælland in Denmark for the implementation of digital pathology solutions, CaloPix®. This strategic collaboration aims to modernize pathology services, enhancing efficiency, accuracy, and innovation in diagnostics across Region Sjælland. Read More
Press Release
Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report. Read More
Press Release
PharmaNest Launches Its Digital Pathology Spatially Resolved, Quantitative Tissue Panels to Quantify Tissue Injury and Inflammation in the Context of Fibrotic Conditions
PharmaNest, a leader in high resolution quantitative Digital Pathology and Artificial Intelligence, announces today the launch new quantitative tissue panels to properly quantify tissue injury and inflammation in the context of multiple fibrotic conditions, from discovery models to clinical development. Such spatially resolved datasets can be fused with other spatially resolved biology methods. Read More
Press Release
PharmaNest to Present Six Digital Pathology Abstracts at the International Liver Congress-EASL 2023, Including Liver Related Clinical Outcomes Prediction Results in NASH
PharmaNest, a leader in high resolution, single-fiber, quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest Ph-FCS continuous fibrosis biomarker for the quantification of the severity of fibrosis and prognostics of liver related clinical events in NASH. Read More
Press Release
Owkin Rolls Out Its Landmark AI Diagnostic Within Medipath, the Largest Network of Pathologists in France
World's first AI diagnostic for MSI prescreening from routine H&E slides for colorectal cancer aims to help pathologists and oncologists facilitate better access to approved immunotherapy treatments for their patients. Read More
Press Release
Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis
EMA offers endorsement for AI optimization of clinical trials. Two Owkin AI models significantly improve the discrimination accuracy for overall survival in hepatocellular carcinoma and mesothelioma. Owkin to develop on-demand prognostic scores for other indications to further reduce clinical trial failure rates Read More
Press Release
Tribun Health Joins the UniHA Network, the Largest Group Purchasing Organization in France, for a Four-Year Term Through Its Digital Pathology Solution
In response to a call for tenders, Tribun Health had to undergo numerous evaluations and a rating system before joining the UniHA network in digital pathology. Read More
Press Release
PharmaNest Presents NASH Digital Pathology and AI Results With a Performance That Compares to Histological Stages and Imaging Methods at the Liver Meeting® | AASLD 2022
PharmaNest, an emerging leader in quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest continuous scores for the quantification of the treatment effects of NASH therapies at the 2022 Liver Meeting® | AASLD conference Read More
Press Release
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) enter a strategic partnership to use artificial intelligence (AI) powered tool for the diagnosis and staging of NASH (non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D). Read More
Press Release
Tribun Health Enters a Strategic Partnership With Mindpeak to Provide Pathologists With the Most Advanced AI Diagnostic Tool for Breast Cancer
Mindpeak breast cancer algorithms have been seamlessly integrated into the gold-standard image management software, CaloPix 5, enhancing the pathologist's possibilities. Read More
Press Release
PharmaNest to Present Eight Digital Pathology and AI Abstracts at the International Liver Congress 2022
PharmaNest, an emerging leader in quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest continuous score for the quantification of the severity of fibrosis and treatment effects of NASH therapies at the 2022 International Liver Conference. Read More
Press Release
PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the AASLD - The Liver Meeting Digital Experience™ (TLMdX) 2021
New digital pathology, quantitative image analysis and quantitative AI method for liver tissues is presented for the continuous assessment of the histological phenotype(s) of fibrosis, including severity and regression of fibrosis in Human in-vitro 3D NASH Spheroid models, NASH rodent models, Clinical Phase2b NASH Studies at the Liver Meeting Digital Experience™ 2021 Read More
Press Release
PharmaNest Announces New Pre-Clinical NASH and Clinical Liver Cancer Data to Be Presented at the AASLD | the Liver Meeting Digital ExperienceTM (TLMdX) 2020
New digital image analysis data of stained tissues and biopsies with FibroNest is presented for the continuous assessment of the severity and regression of Fibrosis in human in-vitro 3D NASH Spheroid models and for the automated classification of post-transplant patients in F4 Fibrosis Stage with and without Hepatocellular carcinoma (HCC) at the Liver Meeting Digital Experience 2020 Read More
Press Release
Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus
By combining Deciphex's unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI. Read More
Press Release
PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the EASL | Digital International Liver Congress 2020
New digital image analysis data of stained tissues and biopsies with FibroNest is presented for the continuous assessment of the severity and progression of fibrosis in NASH in pre-clinical tissues and adult NASH biopsies at the Digital International Liver CongressTM 2020 Read More
Press Release
PharmaNest Announces Kidney and Lung Fibrosis Quantification Data to Be Presented at the 2020 Fibrosis and Tissue Repair Keystone Symposium
New image analysis data of tissues with FibroNest™ is presented for the continuous assessment of the severity and progression of fibrosis in Kidney and Lung preclinical models at the Fibrosis and Tissue Repair 2020 Keystone Symposium. FibroNest image analysis tool provides the most advanced cloud-based phenotypic image analysis and translational platform for the automated quantification of fibrosis across multiple fibrotic conditions and organs for drug discovery and drug development projects. Read More
Press Release
PharmaNest Announces New Adult and Pediatric NASH Data to Be Presented at the AASLD - Liver Meeting® 2019
New image analysis data of biopsies with FibroNest is presented for the continuous assessment of the severity and progression of fibrosis in NASH in both adult and pediatric cohorts at the Liver Meeting® 2019. Read More
Press Release
PharmaNest Launches FibroNest, the First Multivendor Image Analysis and Translational Platform for the Assessment of the Severity and Progression of Fibrosis in NASH
FibroNest cloud-based image analysis tool provides the most advanced phenotypic image analysis and translational platform for the automated quantification of fibrosis and steatosis for NASH and for other fibrotic conditions in drug discovery and drug development projects. Read More
Press Release
InvitroCue and TissueGnostics Team Up to Provide Image Analysis Services in Asia
InvitroCue, a Singapore based provider of products and services for in vitro DMPK, in vitro toxicology and digital pathology, and TissueGnostics, a developer of image acquisition and image cytometry instruments based in Vienna, have signed a term sheet to promote an jointly offer their solutions in Singapore and other Asian countries. Read More
Press Release
Pathology Diagnostics Ltd (PDL) Presence at Dako Symposium Strengthens Industry Connections
Senior technical management staff from Pathology Diagnostics attended the recent DakoLink-UP Scientific Symposium held in York in June 2014. Their presence strengthened connections already in place with Dako staff, and highlighted similarities in qua Read More
Press Release
Pathology Diagnostics Ltd (PDL) Launches Social Media Presence Online
Having already established itself as one of the leaders in its industry, Pathology Diagnostics is continuing to grow from strength to strength - evolving into a formidable organisation within its market space. Wanting to showcase its employee experti Read More
Press Release